Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-07

Clinical Trial Update: A Study of Ibuprofen 250 mg / Acetaminophen 500 mg Comparing The Antipyretic Effects in Healthy Male Volunteers [Phase 3]

View source ↗

Summary

Phase 3 trial comparing antipyretic effects of ibuprofen 250 mg plus acetaminophen 500 mg in healthy volunteers with fever outcomes; completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen 250 mg / Acetaminophen 500 mg

Snippet

Sponsor: Pfizer | Conditions: Fever | Phase 3 | Status: COMPLETED | Results posted: 2018-12-07